| Product Code: ETC9691920 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Peptide Therapeutics Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Peptide Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Thailand Peptide Therapeutics Market - Industry Life Cycle |
3.4 Thailand Peptide Therapeutics Market - Porter's Five Forces |
3.5 Thailand Peptide Therapeutics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Thailand Peptide Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Thailand Peptide Therapeutics Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Thailand Peptide Therapeutics Market Revenues & Volume Share, By Types of Peptide, 2021 & 2031F |
3.9 Thailand Peptide Therapeutics Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.10 Thailand Peptide Therapeutics Market Revenues & Volume Share, By Manufacturing Type, 2021 & 2031F |
4 Thailand Peptide Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Thailand, leading to a higher demand for peptide therapeutics. |
4.2.2 Growing investment in healthcare infrastructure and research development activities in Thailand. |
4.2.3 Favorable government initiatives and policies supporting the development and adoption of peptide therapeutics in the country. |
4.3 Market Restraints |
4.3.1 High cost associated with peptide therapeutics development and production, impacting market accessibility. |
4.3.2 Limited awareness and understanding among healthcare professionals and patients about the benefits of peptide therapeutics. |
4.3.3 Stringent regulatory requirements and lengthy approval processes for peptide drugs in Thailand. |
5 Thailand Peptide Therapeutics Market Trends |
6 Thailand Peptide Therapeutics Market, By Types |
6.1 Thailand Peptide Therapeutics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Thailand Peptide Therapeutics Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Thailand Peptide Therapeutics Market Revenues & Volume, By Innovative, 2021- 2031F |
6.1.4 Thailand Peptide Therapeutics Market Revenues & Volume, By Generic, 2021- 2031F |
6.2 Thailand Peptide Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Thailand Peptide Therapeutics Market Revenues & Volume, By Metabolic, 2021- 2031F |
6.2.3 Thailand Peptide Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.4 Thailand Peptide Therapeutics Market Revenues & Volume, By Gastrointestinal, 2021- 2031F |
6.2.5 Thailand Peptide Therapeutics Market Revenues & Volume, By Cardiovascular, 2021- 2031F |
6.2.6 Thailand Peptide Therapeutics Market Revenues & Volume, By Neurological, 2021- 2031F |
6.2.7 Thailand Peptide Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Thailand Peptide Therapeutics Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Thailand Peptide Therapeutics Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.3 Thailand Peptide Therapeutics Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.4 Thailand Peptide Therapeutics Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Thailand Peptide Therapeutics Market, By Types of Peptide |
6.4.1 Overview and Analysis |
6.4.2 Thailand Peptide Therapeutics Market Revenues & Volume, By Native Peptides, 2021- 2031F |
6.4.3 Thailand Peptide Therapeutics Market Revenues & Volume, By Analog Peptides, 2021- 2031F |
6.4.4 Thailand Peptide Therapeutics Market Revenues & Volume, By Heterologous Peptides, 2021- 2031F |
6.5 Thailand Peptide Therapeutics Market, By Technology |
6.5.1 Overview and Analysis |
6.5.2 Thailand Peptide Therapeutics Market Revenues & Volume, By Liquid Phase, 2021- 2031F |
6.5.3 Thailand Peptide Therapeutics Market Revenues & Volume, By Solid phase, 2021- 2031F |
6.5.4 Thailand Peptide Therapeutics Market Revenues & Volume, By Hybrid, 2021- 2031F |
6.6 Thailand Peptide Therapeutics Market, By Manufacturing Type |
6.6.1 Overview and Analysis |
6.6.2 Thailand Peptide Therapeutics Market Revenues & Volume, By In-house, 2021- 2031F |
6.6.3 Thailand Peptide Therapeutics Market Revenues & Volume, By CMO, 2021- 2031F |
7 Thailand Peptide Therapeutics Market Import-Export Trade Statistics |
7.1 Thailand Peptide Therapeutics Market Export to Major Countries |
7.2 Thailand Peptide Therapeutics Market Imports from Major Countries |
8 Thailand Peptide Therapeutics Market Key Performance Indicators |
8.1 Research and development expenditure allocated to peptide therapeutics in Thailand. |
8.2 Number of clinical trials conducted for peptide-based drugs in the country. |
8.3 Adoption rate of peptide therapeutics by healthcare facilities and practitioners in Thailand. |
9 Thailand Peptide Therapeutics Market - Opportunity Assessment |
9.1 Thailand Peptide Therapeutics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Thailand Peptide Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Thailand Peptide Therapeutics Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Thailand Peptide Therapeutics Market Opportunity Assessment, By Types of Peptide, 2021 & 2031F |
9.5 Thailand Peptide Therapeutics Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.6 Thailand Peptide Therapeutics Market Opportunity Assessment, By Manufacturing Type, 2021 & 2031F |
10 Thailand Peptide Therapeutics Market - Competitive Landscape |
10.1 Thailand Peptide Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Thailand Peptide Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here